Background
Methods
Patient selection
Work-up
Infarct patterns
Statistical analysis
Results
Quartile of DWI lesion volumes, ml |
P
| ||||
---|---|---|---|---|---|
Q1 (< 3.1) n = 58 | Q2 (3.1-11.8) n = 58 | Q3 (11.9-44.2) n = 58 | Q4 (> 44.2) n = 57 | (Q4 vs. others) | |
NISS score on admission | 4.0 ± 3.9 | 8.1 ± 6.1 | 10.8 ± 6.5 | 15.1 ± 6.8 | < 0.001 |
Vascular risk factors | |||||
Age | 69.0 ± 10.9 | 70.0 ± 11.1 | 72.5 ± 10.4 | 69.5 ± 11.7 | 0.547 |
Male gender | 24(41.4%) | 26(44.8%) | 32(55.2%) | 36(63.2%) | 0.036 |
Hypertension | 41(70.7%) | 41(70.7%) | 42(72.4%) | 36(63.2%) | 0.250 |
Diabetes | 10(17.2%) | 13(22.4%) | 7(12.1%) | 14(24.6%) | 0.222 |
Previous TIA/stroke | 18(31.0%) | 15(25.9%) | 13(22.4%) | 13(22.8%) | 0.585 |
CHADS2*score | 0.871 | ||||
0-1 | 28(48.3.%) | 24(41.4%) | 25(43.1%) | 25(43.9%) | |
2-3 | 22(37.9%) | 27(6.6%) | 28(48.3%) | 24(42.1%) | |
4-5 | 8(13.8%) | 7(12.1%) | 5(8.6%) | 8(14.0%) | |
Dysrhythmia | |||||
Paroxysmal atrial fibrillation | 22(37.9%) | 22(37.9%) | 20(34.5%) | 18(31.6%) | 0.476 |
Concomitant valvular heart disease | 5(8.8%) | 9(15.5%) | 5(8.6%) | 5(8.9%) | 0.663 |
Heart rate (/min) | 78.1 ± 19.2 | 82.9 ± 21.6 | 85.1 ± 21.4 | 84.2 ± 23.2 | 0.480 |
Medications prior to onset | |||||
Antiplatelet agents user | 26(45.6%) | 20(34.5%) | 26(47.3%) | 19(33.3%) | 0.229 |
Warfarin user | 7(12.1%) | 9(15.5%) | 4(6.9%) | 8(14.0%) | 0.610 |
Laboratory findings | |||||
D-dimer, mg/dL | 1.51 ± 2.85 | 2.01 ± 3.31 | 3.45 ± 12.87 | 2.06 ± 3.35 | 0.035 |
Fibrinogen, mg/dL | 320.0 ± 83.9 | 303.0 ± 79.2 | 335.5 ± 81.9 | 346.6 ± 100.2 | 0.122 |
C-reactive protein, mg/dL | 1.13 ± 2.95 | 0.69 ± 1.78 | 0.95 ± 2.04 | 0.80 ± 1.31 | 0.068 |
Prothrombin Time, INR | 1.07 ± 0.11 | 1.10 ± 0.12 | 1.06 ± 0.11 | 1.06 ± 0.10 | 0.373 |
Transthoracic echocardiogram finding | |||||
Left ventricular ejection fraction, % | 62.1 ± 9.8 | 59.7 ± 12.4 | 60.2 ± 8.5 | 56.1 ± 15.4 | 0.020 |
Left atrium size, ml | 48.0 ± 8.8 | 46.5 ± 9.4 | 47.8 ± 8.6 | 46.5 ± 7.2 | 0.660 |
E/e' ratio | 13.20 ± 6.25 | 16.76 ± 9.85 | 13.84 ± 8.06 | 14.52 ± 9.00 | 0.839 |
DT, ms | 230.5 ± 153.6 | 248.3 ± 154.5 | 207.3 ± 115.8 | 216.1 ± 114.2 | 0.925 |
DWI lesion patterns |
P
| |||
---|---|---|---|---|
Territory n = 46 (19.9%) | Lobar/Deep n = 118 (51.1%) | Small scattered n = 67 (29.0%) | (Territory vs. others) | |
NIHSS score on admission | 16.3 ± 6.3 | 9.6 ± 6.1 | 4.1 ± 4.2 | < 0.001 |
Vascular risk factors | ||||
Age | 68.3 ± .12.4 | 71.6 ± 11.4 | 69.3 ± 9.3 | 0.324 |
Male gender | 29(63.0%) | 57(48.3%) | 32(47.8%) | 0.070 |
Hypertension | 28(60.9%) | 84(71.2%) | 48(71.6%) | 0.733 |
Diabetes | 10(21.7%) | 20(16.9%) | 14(20.9%) | 0.603 |
Previous TIA/stroke | 13(28.3%) | 25(21.2%) | 21(31.3%) | 0.636 |
CHADS2*score | 0.684 | |||
0-1 | 21(45.7%) | 51(43.2%) | 30(44.8%) | |
2-3 | 18(39.1%) | 55(46.6%) | 28(41.8%) | |
4-5 | 7(15.2%) | 12(10.2%) | 9(13.4%) | |
Dysrhythmia | ||||
Paroxysmal atrial fibrillation | 15(32.6%) | 44(37.3%) | 23(34.3%) | 0.647 |
Concomitant valvular heart disease | 5(11.1%) | 14(12.0%) | 5(7.5%) | 0.878 |
Heart rate (/min) | 84.2 ± 25.1 | 84.2 ± 21.0 | 79.8 ± 19.9 | 0.501 |
Medications prior to onset | ||||
Antiplatelet agents user | 15(32.6%) | 45(39.1%) | 31(47.0%) | 0.246 |
Warfarin user | 8(17.4%) | 12(10.2%) | 8(11.9.%) | 0.221 |
Laboratory findings | ||||
D-dimer, mg/dL | 2.37 ± 3.76 | 1.89 ± 3.19 | 1.29 ± 2.03 | 0.105 |
Fibrinogen, mg/dL | 340.72 ± 100.6 | 324.5 ± 88.0 | 319.4 ± 77.7 | 0.230 |
C-reactive protein, mg/dL | 0.84 ± 1.14 | 0.93 ± 2.22 | 0.87 ± 2.41 | 0.041 |
Prothrombin Time, INR | 1.08 ± 0.11 | 1.07 ± 0.12 | 1.08 ± 0.10 | 0.667 |
Transthoracic echocardiogram finding | ||||
Left ventricular ejection fraction, % | 55.6 ± 16.3 | 60.0 ± 10.2 | 61.1 ± 11.1 | 0.008 |
Left atrium size, ml | 47.2 ± 7.5 | 47.8 ± 9.2 | 46.4 ± 8.1 | 0.991 |
E/e' ratio | 14.53 ± 10.21 | 15.11 ± 9.00 | 13.71. ± 6.16 | 0.478 |
DT, ms | 237.4 ± 131.9 | 215.9 ± 118.9 | 244.8 ± 163.3 | 0.317 |